Online Only Articles

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption

Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Department of Hematology, Hospital Central de Asturias, Oviedo
Department of Hematology, Hospital Central de Asturias, Oviedo
Department of Hematology, Hospital Clínico, Salamanca
qGenomics Laboratories, Barcelona, Spain
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Vol. 99 No. 11 (2014): November, 2014 https://doi.org/10.3324/haematol.2014.108365